Mesoblast (MESO) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mesoblast Limited has announced that their Director, Dr. Eric Rose, acquired 21,428 American Depositary Shares (ADS) on the market, valued at US$142,318.35. This transaction has subsequently increased Dr. Rose’s indirect interest in the company, with each ADS representing 10 ordinary shares. Additionally, Dr. Rose is set to receive 5,039,814 ordinary shares, pending shareholder approval at Mesoblast’s 2024 Annual General Meeting.
For further insights into MESO stock, check out TipRanks’ Stock Analysis page.